Document and Entity Information Document Type Document Annual Report Document Period End Date Document Transition Report Entity File Number Entity Registrant Name Entity Incorporation, State or Country Code Entity Tax Identification Number Entity Address, Address Line One Entity Address, City or Town Entity Address, State or Province Entity Address, Postal Zip Code City Area Code Local Phone Number Title of 12(b) Security Trading Symbol Security Exchange Name Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company ICFR Auditor Attestation Flag Entity Shell Company Entity Shell Company Entity Common Stock, Shares Outstanding Entity Central Index Key Current Fiscal Year End Date Document Fiscal Year Focus Document Fiscal Period Focus Amendment Flag Auditor Name Auditor Firm ID Auditor Location Entity Well-known Seasoned Issuer Entity Public Float Entity Voluntary Filers CONSOLIDATED BALANCE SHEETS Assets [Abstract] ASSETS Assets, Current [Abstract] Current assets: Cash and Cash Equivalents, at Carrying Value Cash and cash equivalents Cash and cash equivalents Restricted Cash, Current Restricted cash Prepaid Expense, Current Prepaid expenses and deposits Other Receivables, Net, Current Other receivables Assets, Current Total current assets Assets, Noncurrent [Abstract] Non-current assets: Amount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Excludes construction in progress. Property, Plant and Equipment Other Than Construction in Progress Property, plant and equipment, net Construction in Progress, Gross Construction in progress Operating lease, right-of-use asset Operating lease, right-of-use asset Right-of-use assets, net Assets, Noncurrent Total non-current assets Assets Total assets Liabilities and Equity [Abstract] LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities, Current [Abstract] Current liabilities: Accounts Payable and Accrued Liabilities, Current Accounts payable and accrued liabilities Total accounts payable and accrued liabilities Due to Related Parties, Current Related party deferred revenue Deferred Revenue, Current Deferred revenue Operating Lease, Liability, Current Lease liability Liabilities, Current Total current liabilities Liabilities, Noncurrent [Abstract] Non-current liabilities: Operating Lease, Liability, Noncurrent Lease liability, net of current portion Liabilities, Noncurrent Total non-current liabilities Liabilities Total liabilities Stockholders' Equity Attributable to Parent [Abstract] Stockholders' equity: Preferred Stock, Value, Issued Preferred stock - $0.001 par value, 5 million shares authorized and 0 shares issued and outstanding at December 31, 2022 and 2021, respectively Common Stock, Value, Issued Common stock, $0.001 par value, 30 million and 15 million shares authorized, 8.4 million and 8.3 million shares issued and outstanding as of December 31, 2022 and 2021, respectively Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Ending Balance Beginning Balance Total stockholders' equity Liabilities and Equity Total liabilities and stockholders' equity Preferred Stock, Par or Stated Value Per Share Preferred stock par value (per share) Preferred Stock, Shares Authorized Preferred stock authorized Preferred Stock, Shares Issued Preferred stock issued Preferred Stock, Shares Outstanding Preferred stock outstanding Common Stock, Par or Stated Value Per Share Common stock par value (per share) Common Stock, Shares Authorized Common stock authorized Common Stock, Shares, Issued Common stock issued Common Stock, Shares, Outstanding Common stock outstanding CONSOLIDATED STATEMENTS OF OPERATIONS Statement [Table] INCOME TAXES Product and Service [Axis] Product and Service [Domain] Grant [Member] Grant income Service [Member] Related party service revenue Statements LIQUIDITY, GOING CONCERN AND FINANCIAL CONDITION Statement Revenues [Abstract] Revenues: Revenue from Contract with Customer, Including Assessed Tax Revenue recognized Total revenues Costs and Expenses [Abstract] Operating expenses: Research and Development Expense Research and development General and Administrative Expense General and administrative Operating Expenses Total operating expenses Operating Income (Loss) Loss from operations Nonoperating Income (Expense) [Abstract] Other income (expenses): The amount of gain (loss) pertaining to the arbitration that was charged against earnings in the period. Gain (Loss) Related to Arbitration Settlement Arbitration settlement Investment Income, Interest Interest income Net Income (Loss) Attributable to Parent Net loss Net loss Earnings Per Share, Basic Net loss per share, basic Net loss per share, basic Earnings Per Share, Diluted Net loss per share, diluted Net loss per share, diluted Weighted Average Number of Shares Outstanding, Basic Weighted average number of common shares outstanding, basic Weighted average common shares outstanding, Basic Weighted Average Number of Shares Outstanding, Diluted Weighted average number of common shares outstanding, diluted Weighted average common shares outstanding, Diluted CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY Equity Components [Axis] Equity Component [Domain] Common Stock [Member] Common Stock Additional Paid-in Capital [Member] Additional Paid- in Capital Retained Earnings [Member] Accumulated Deficit Shares, Issued Ending Balance, Shares Beginning Balance, Shares Stock Issued During Period, Value, New Issues Issuance of common shares for cash Aggregate proceeds from shares issued under the purchase agreement Stock Issued During Period, Shares, New Issues Issuance of common shares for cash (in shares) Number of shares issued Stock Issued During Period, Value, Stock Options Exercised Stock options exercised for cash Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Stock options exercised for cash (in shares) Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture Stock-based compensation Shares Issued, Shares, Share-Based Payment Arrangement, before Forfeiture Aggregate shares of common stock Stock-based compensation (in shares) Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs Net of offering costs CONSOLIDATED STATEMENTS OF CASH FLOWS Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities: Net Income (Loss), Including Portion Attributable to Noncontrolling Interest Net loss Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities [Abstract] Reconciliation of net loss to net cash used in operating activities: Depreciation, Depletion and Amortization Depreciation and amortization Share-Based Payment Arrangement, Noncash Expense Stock-based compensation Operating Lease, Right-of-Use Asset, Amortization Expense Amortization on right-of-use assets Gain (Loss) on Disposition of Assets Loss on disposal of fixed assets Amount of gain (loss) on termination of lease before expiration of leases term. Gain Loss On Termination Of Leases Gain on lease termination Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Prepaid Expense Prepaid expenses and deposits Increase (Decrease) in Accrued Interest Receivable, Net Other receivables Increase (Decrease) in Accounts Payable and Accrued Liabilities Accounts payable and accrued expenses Increase (Decrease) in Due to Related Parties, Current Related party deferred revenue Increase (Decrease) in Deferred Revenue Deferred revenue Increase (Decrease) in Operating Lease Liability Lease liability Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Investing Activities [Abstract] Cash Flows from Investing Activities: The cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; excluding cash outflows to pay for construction of self-constructed assets. Payments to Acquire Property, Plant, and Equipment Excluding Construction In Progress Purchase of property and equipment The cash outflow for acquisition of Construction in Progress. Payments For Construction in Progress Purchase of construction in progress Net Cash Provided by (Used in) Investing Activities Net cash used in investing activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash Flows from Financing Activities: Proceeds from Issuance of Common Stock Proceeds from Issuance of Common Stock Proceeds from issuance of common stock, net Proceeds from Stock Options Exercised Proceeds from exercise of stock options Net Cash Provided by (Used in) Financing Activities Net cash provided by financing activities Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect Net (decrease) increase in cash, cash equivalents and restricted cash Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents Cash, cash equivalents and restricted cash at end of the period Cash, cash equivalents and restricted cash at beginning of the period Total cash, cash equivalents and restricted cash shown in statements of cash flows Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental schedule of non-cash financing and investing activities: Amount of reclassifications between construction in progress and fixed assets Reclassifications Between Construction in Progress and Fixed Assets Reclassifications between construction in progress and fixed assets Capital Expenditures Incurred but Not yet Paid Capital expenditures included in accounts payable Amount of changes to right-of-use assets and lease liability due to close out of an operating lease. Change To Right Of Use Assets And Lease Liability Due To Close Out Of An Operating Lease Changes to right-of-use assets and lease liability due to close out of operating leases NATURE OF OPERATIONS Nature of Operations [Text Block] NATURE OF OPERATIONS n/a FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS Liquidity Financial Condition And Going Concern Text Block Liquidity Financial Condition And Going Concern [Text Block] FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS SIGNIFICANT ACCOUNTING POLICIES Significant Accounting Policies [Text Block] SIGNIFICANT ACCOUNTING POLICIES NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDERS Noncontrolling Interest Disclosure [Text Block] NET LOSS PER SHARE APPLICABLE TO COMMON SHAREHOLDERS OTHER RECEIVABLE Loans, Notes, Trade and Other Receivables Disclosure [Text Block] OTHER RECEIVABLE PROPERTY AND EQUIPMENT Property, Plant and Equipment Disclosure PROPERTY AND EQUIPMENT LEASES Lessee, Operating Leases [Text Block] LEASES ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts Payable and Accrued Liabilities Disclosure [Text Block] ACCOUNTS PAYABLE AND ACCRUED LIABILITIES RELATED PARTY DEFERRED REVENUE The entire disclosure for related party liability. Related Party Liability, Disclosure [Text Block] RELATED PARTY DEFERRED REVENUE STOCK OPTION PLANS. Stockholders' Equity Note Disclosure [Text Block] STOCKHOLDERS' EQUITY WARRANTS The entire disclosure for information about warrants. Warrants Disclosure [Text Block] WARRANTS STOCK OPTION PLANS Disclosure of Compensation Related Costs, Share-based Payments [Text Block] STOCK OPTION PLANS GRANT INCOME Revenue from Contract with Customer [Text Block] GRANT INCOME LEGAL PROCEEDINGS Legal Matters and Contingencies [Text Block] LEGAL PROCEEDINGS No definition available. RELATED PARTY TRANSACTIONS Related Party Transactions Disclosure [Text Block] RELATED PARTY TRANSACTIONS INCOME TAXES Income Tax Disclosure [Text Block] INCOME TAXES SUBSEQUENT EVENTS Subsequent Events [Text Block] SUBSEQUENT EVENTS Basis of Accounting, Policy [Policy Text Block] Basis of Presentation Consolidation, Policy [Policy Text Block] Principles of Consolidation Use of Estimates, Policy [Policy Text Block] Use of Estimates Cash and Cash Equivalents, Policy [Policy Text Block] Cash, Cash Equivalents, Restricted Cash and Credit Risk Disclosure of accounting policy for the Retain existing policy. RetainExistingPolicy [Policy Text Block] Property and Equipment Disclosure of accounting policy for property and equipment, construction in progress. Property And Equipment Construction In Progress, Policy [Policy Text Block] Property and equipment - Construction in Progress Impairment or Disposal of Long-Lived Assets, Policy [Policy Text Block] Impairment Testing of Long-Lived Assets and Right-Of-Use Assets Intangible Assets, Finite-Lived, Policy [Policy Text Block] Patents and Patent Application Costs Share-Based Payment Arrangement, Director [Policy Text Block] Stock-Based Compensation Research and Development Expense, Policy [Policy Text Block] Research and Development Costs Income Tax, Policy [Policy Text Block] Income Taxes Disclosure of accounting policy for grant income. Grant Income, Policy [Policy Text Block] Grant Income Earnings Per Share, Policy [Policy Text Block] Loss per Common Share New Accounting Pronouncements, Policy [Policy Text Block] New Accounting Standards Tabular disclosure of the components of cash and cash equivalents, restricted cash. Schedule of Cash and Cash Equivalents, Restricted Cash [Table Text Block] SIGNIFICANT ACCOUNTING POLICIES Schedule of Earnings Per Share, Basic and Diluted [Table Text Block] Schedule of computation of net loss per share Tabular disclosure of net loss per share. Net Loss Per Share [Table Text Block] Schedule of anti-dilutive securities Schedule of property and equipment Schedule of property and equipment Tabular disclosure of lease cost and other information related to operating leases. Schedule Of Lease Cost And Other Information Related to Operating Leases [Table Text Block] Schedule of quantitative information about operating leases Lessee, Operating Lease, Liability, Maturity [Table Text Block] Schedule of maturities of operating leases Schedule of Accounts Payable and Accrued Liabilities [Table Text Block] Schedule of accounts payable and accrued liabilities Warrant [Member] Common stock purchase warrants Tabular disclosure of share purchase warrants. Share Purchase Warrants [Table Text Block] Schedule of share purchase warrants Share-based Payment Arrangement, Activity [Table Text Block] Summary of the company's stock option activity Schedule or Description of Weighted Average Discount Rate [Table Text Block] Schedule or description of weighted average discount rate Tabular disclosure of stock based compensation expenses recorded. Stock based Compensation Expenses [Table Text Block] Schedule of stock-based compensation expenses Schedule of Related Party Transactions, by Related Party [Table] Related Party Transaction [Line Items] RELATED PARTY TRANSACTIONS RELATED PARTY LIABILITY Schedule of Related Party Transactions [Table Text Block] Schedule of related party transaction expenses recorded during the respective periods Schedule of Deferred Tax Assets and Liabilities [Table Text Block] Schedule of Deferred Tax Assets and Liabilities Tabular disclosure of expected tax expense benefit based on federal statutory rate is reconciled with actual tax provision benefit. Summary Of Expected Tax Expense Benefit Based On Federal Statutory Rate is Reconciled With Actual Tax Provision Benefit [Table Text Block] Summary Of Expected Tax Expense Benefit Based On Federal Statutory Rates Reconciled With Actual Tax Provision Benefit Disclosure of information about organization, consolidation and presentation of financial statements. Organization, Consolidation and Presentation of Financial Statements Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum Minimum [Member] Minimum Subsequent Event Type [Axis] Subsequent Event Type [Domain] Subsequent Event [Member] Subsequent event Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Organization, Consolidation and Presentation of Financial Statements [Line Items] NATURE OF OPERATIONS Stockholders' Equity, Reverse Stock Split Reverse stock split The amount of stock issued during period, value, reverse stock splits Stock Issued During Period, Value, Reverse Stock Splits Reverse stock split value Schedule reflecting a Statement of Income, Statement of Cash Flows, Statement of Financial Position, Statement of Shareholders' Equity and Other Comprehensive Income, or other statement as needed. FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS [Table] Type of Arrangement and Non-arrangement Transactions [Axis] Arrangements and Non-arrangement Transactions [Domain] Represents the information pertaining to controlled equity offering sales agreement. Controlled Equity Offering Sales Agreement [Member] ATM Agreement This member stands for binding services agreement. Binding Services Agreement [Member] Binding Services Agreement Counterparty Name [Axis] Counterparty Name [Domain] Represents the information pertaining to Cantor Fitzgerald & Co and RBC Capital Markets, LLC. Cantor Fitzgerald Co. And Rbc Capital Markets Llc [Member] Sales Agents Related Party [Axis] Related Party [Domain] Represents information pertaining to Clinical Trial Agreement with Wilson Wolf Manufacturing Corporation. Wilson Wolf Manufacturing Corporation [Member] Wilson Wolf Manufacturing Corporation The information pertaining to Lincoln Park. Lincoln Park [Member] Lincoln Park Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS [Line Items] FINANCIAL CONDITION, GOING CONCERN AND MANAGEMENT PLANS Cash, Cash Equivalents, Restricted Cash, and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect Cash and cash equivalents Common Stock, Value, Subscriptions Aggregate offering price Represents the percent of calculation of compensation rate by using gross sales price per share sold. Common Stock, Shares, Commission Rate Calculation on Gross Sales Price per Share, Percent Commission rate Stock Issued During Period, Value, Issued for Services Stock issued during period for services Research and Development Arrangement, Contract to Perform for Others, Compensation Earned Amount of notice received Funds Received From Grant Funds received from CPRIT grant Funds received from CPRIT grant Revenue From Grant Related to CPRIT. Revenue From Grant Related to CPRIT Revenue from CPRIT Contract with Customer, Liability, Revenue Recognized Revenue recognized Amount of grant income transfer product and service to customer for which consideration has been received or is receivable. Grant Received Grant income received Stock Issued During Period, Value, Other Stock issued during period other Stock Issued During Period, Shares, Other Stock issued during period other (in shares) Represents the amount of commitment fees. Commitment Fee Commitment fee Amount of revenue recognized for grant from FDA's Orphan Products Grant program. Revenue From Orphan Products Grant Program Grant revenue Amount of receivable from FDA's Orphan Products Grant program. Orphan Products Grant Program Grant income receivable Funds received from CPRIT grant Funds Received From Grant Funds received from CPRIT grant Schedule reflecting a significant accounting policies. Significant Accounting Policies [Table] Project [Axis] Project [Domain] n/a Manufacturing facility in Houston, Texas Manufacturing facility in Houston, Texas Line items reflecting a significant accounting policies. Significant Accounting Policies [Line Items] Significant Accounting Policies Cash, FDIC Insured Amount Cash, FDIC insured amount Cash, Uninsured Amount Cash, uninsured amount Receipt of product development research award Receipt Of Product Development Research Award Receipt of product development research award Amount of grant income receivable by the company, as of the balance sheet date. Grant Income Receivable Grant income receivable The amount of Award grant from orphan product grant program. Amount Of Award Grant From Orphan Product Grant Program Amount of award grant from orphan product grant program Schedule of Antidilutive Securities Excluded from Computation of Earnings Per Share [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] NET LOSS PER SHARE Net Income (Loss) Attributable to Parent, Diluted [Abstract] Numerator: Weighted Average Number of Shares Outstanding, Diluted [Abstract] Denominator: Earnings Per Share [Abstract] Net loss per share: Antidilutive Securities [Axis] Antidilutive Securities, Name [Domain] Share-Based Payment Arrangement, Option [Member] Common stock options Common stock warrants - equity treatment. Common Stock Warrants Equity Treatment Common stock purchase warrants Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount Potentially dilutive securities Schedule of Receivables with Imputed Interest [Table] The information pertaining to cancer Ppevention And Research Institute Of Texas. Cancer Prevention And Research Institute Of Texas [Member] Cancer Prevention And Research Institute Of Texas Receivables with Imputed Interest [Line Items] OTHER RECEIVABLE Reimbursements Reimbursements Property, Plant and Equipment [Table] Property, Plant and Equipment, Type [Axis] Property, Plant and Equipment, Type [Domain] Lab and manufacturing equipment Lab and manufacturing equipment Long lived, depreciable assets that are used in the creation, maintenance and utilization of information systems. Computers, equipment and software Computers, equipment and software Office furniture Office furniture Leasehold improvements Leasehold improvements Property, Plant and Equipment [Line Items] PROPERTY AND EQUIPMENT Property, Plant and Equipment, Gross Total Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment Less: accumulated depreciation Amount of structure or a modification to a structure under construction. Includes recently completed structures or modifications to structures that have not been placed into service. Construction in Progress Construction in progress Property, Plant and Equipment, Net Total fixed assets, net Property, Plant and Equipment, Useful Life Estimated Useful Lives Depreciation Depreciation expense Amount of reduction in operating lease liabilities for termination of lease. Decrease In Operating Lease Liabilities For Lease Termination Reduction in operating lease liabilities for lease termination Amount of reduction in operating lease right of use assets for termination of lease. Decrease In Operating Lease Right Of Use Assets For Lease Termination Reduction in right-of-use assets for lease termination Operating lease, liability Operating lease liabilities included in the Condensed Consolidated Balance Sheet at December 31, 2022 Total operating lease liabilities No definition available. Operating Lease Expense [Abstract] Operating lease expense summary: Operating Lease, Cost Operating lease expense Short-term Lease, Cost Short-term lease expense Variable Lease, Cost Variable lease expense Lease, Cost Total No definition available. Other Lease Information [Abstract] Other information: Operating Lease, Payments Operating cash flows - operating leases Operating Lease, Weighted Average Remaining Lease Term Weighted-average remaining lease term - operating leases Operating Lease, Weighted Average Discount Rate, Percent weighted-average discount rate used to determine the operating lease liability Lessee, Operating Lease, Liability, to be Paid, Year One Year ending December 31, 2023 Lessee, Operating Lease, Liability, to be Paid, Year Two Year ending December 31, 2024 Lessee, Operating Lease, Liability, to be Paid, Year Three Year ending December 31, 2025 Lessee, Operating Lease, Liability, to be Paid, Year Four Year ending December 31, 2026 Lessee, Operating Lease, Liability, to be Paid, Year Five Year ending December 31, 2027 Lessee, Operating Lease, Liability, to be Paid, after Year Five Thereafter Lessee, Operating Lease, Liability, to be Paid Total Lessee, Operating Lease, Liability, Undiscounted Excess Amount Less present value discount This table lists the accounts payable and accrued liabilities. The line items identify information about the accounts payable and accrued liabilities. Accounts Payable And Accrued Liabilities [Table] Restructuring Plan [Axis] Restructuring Plan [Domain] This member stands for operational cost reduction plan. Operational Cost Reduction Plan [Member] Operational Cost Reduction Plan Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Accounts Payable And Accrued Liabilities [Line Items] ACCOUNTS PAYABLE AND ACCRUED LIABILITIES Accounts Payable, Current Accounts payable Employee-related Liabilities, Current Compensation and benefits Carrying value as of the balance sheet date of obligations incurred through that date and payable for Process development expenses. Accrued Process Development Expenses, Current Process development expenses Accrued Professional Fees, Current Professional fees Carrying value as of the balance sheet date of Consulting agreements payable. Accrued Technology License Fees Technology license fees Carrying value as of the balance sheet date of obligations incurred through that date and payable for arbitration. Arbitration Settlement Liabilities, Current Arbitration settlement fees Other Accrued Liabilities, Current Other Restructuring and Related Cost, Number of Positions Eliminated, Period Percent Reduction in headcount of general and administrative function (as a percent) Related Party Transaction, Amounts of Transaction Cash payment from related party The amount of advance received from Wilson Wolf Mission for giving non-exclusive training of Wilson Wolf to make, use, and sell Marker's cell culture non-proprietary media formulation. Related Party Advance Received For Non Exclusive Training To Make Use And Sell Marker’s Cell Culture Non Proprietary Media Formulation Advance received for non-exclusive training of Wilson Wolf to make, use, and sell Marker's cell culture non-proprietary media formulation The amount of advance received from Wilson Wolf Mission for giving non-exclusive training of Wilson Wolf to replicate Marker's quality management system inclusive of all underlying documents. Related Party Advance Received For Non Exclusive Training To Replicate Marker’s Quality Management System Inclusive Of All Underlying Documents Advance received for non-exclusive training of Wilson Wolf to replicate Marker's quality management system inclusive of all underlying documents The amount of advance received from Wilson Wolf Mission for giving non-exclusive training of Wilson Wolf to be able to replicate Marker's cGMP-compliant, linearly scalable, G-Rex based T-cell manufacturing process. Related Party Advance Received For Non Exclusive Training To Replicate Marker’s cGMP Compliant Linearly Scalable G-Rex Based T-Cell Manufacturing Process Advance received for non-exclusive training of Wilson Wolf to replicate Marker's cGMP-compliant, linearly scalable, G-Rex based T-cell manufacturing process The amount of advance received under the hired to invent doctrine for Marker to train Wilson Wolf on its expertise in the optimization of T-cell therapy manufacturing processes using G-Rex and to conduct CAR T and TCR G-Rex Optimization Work under the direction of Wilson Wolf (the "Work Direction"). Related Party Advance Received Under The Hired To Invent Doctrine For Marker To Train Wilson Wolf On Its Expertise In The Optimization Of T-Cell Therapy Manufacturing Processes Advance received under the hired to invent doctrine for Marker to train Wilson Wolf on its expertise in the optimization of T-cell therapy manufacturing processes The period for completion of optimization work under the direction of Wilson Wolf which Marker will make good faith efforts. Period For Completion Of Optimization Work Under Direction Of Wilson Wolf Which Marker Will Make Good Faith Efforts From The Agreement Date Period for completion of optimization work under the direction of Wilson Wolf which Marker will make good faith efforts from the agreement date The additional amount agreed to received from Wilson Wolf if the Work Direction is completed within one year from the onset of the agreement. Additional Amount Agreed To Pay If The Work Direction Is Completed Within One Year From The Onset Of The Agreement Additional amount agreed to received from Wilson Wolf if the Work Direction is completed within one year from the onset of the agreement Percentage of threshold minimum combined voting power of the surviving entity or parent corporation of the surviving entity immediately after merger, reorganization or consolidation, or the sale or other transfer of all or substantially all of entity's business or assets considered, in the event if the agreement cannot be fulfilled. Threshold Minimum Combined Voting Power Of Surviving Entity Or Parent Corporation Of Surviving Entity Considered Threshold minimum combined voting power of the surviving entity or parent corporation of the surviving entity considered (in percent) Schedule of Stock by Class [Table] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] This member stands for exercise of Stock Warrants. Exercise of Stock Warrants [Member] Exercise of Stock Warrants This member stands for board compensation. Board Compensation [Member] Board Compensation Class of Stock [Line Items] STOCKHOLDERS' EQUITY Class of Warrant or Right, Number of Securities Called by Warrants or Rights Issuance of shares of common stock Recapitalization Costs Related costs Schedule of common stock capital shares reserved for future issuance. Common Stock Capital Shares Reserved For Future Issuance [Table] Common Stock Capital Shares Reserved For Future Issuance [Table] Sale of Stock [Axis] Sale of Stock [Domain] The member stands for ATM agreement. ATM Agreement [Member] ATM Agreement Plan Name [Axis] Plan Name [Domain] Represents member information pertaining to 2020 equity incentive plan. Equity Incentive Plan 2020 [Member] 2020 Equity Incentive Plan Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Common Stock Capital Shares Reserved For Future Issuance [Line Items] STOCKHOLDERS' EQUITY Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price Exercise price Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value Fair value of common stock Over-Allotment Option [Member] Underwritten Public Offering Represents the number of shares authorized to issue and sell. Number Of Shares Authorized To Issue And Sell Number of shares authorized to issue and sell Share price Share price Represents the underwriting option period. Underwriting Option Period Option period Represents the number of additional shares authorized to issue and sell. Number Of Additional Shares Authorized To Issue And Sell Number of additional shares authorized to issue and sell Number of additional new stock issued during the period. Stock Issued During Period Additional Shares New Issues Number of additional shares issued Represents the amount of offering cost. Offering Cost Offering cost Proceeds from Issuance of Warrants Proceeds from issuance of warrants Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] This Member represents stock purchase agreement Stock Purchase Agreement [Member] Stock Purchase Agreement Subsidiary, Sale of Stock [Line Items] STOCKHOLDERS' EQUITY Class of Warrant or Right, Outstanding Number of Warrants, Ending balance Number of Warrants, Beginning balance Number of warrants expired or cancelled. Number of Warrants, Expired or cancelled Number of Warrants, Expired or cancelled Class Of Warrant Or Rights Outstanding Weighted Average Exercise Price. Class Of Warrant Or Rights Outstanding Weighted Average Exercise Price Weighted Average Exercise Price, Ending Balance Weighted Average Exercise Price, Beginning Balance Class of warrant or rights outstanding exercised weighted average exercise price. Class Of Warrant Or Rights Outstanding Exercised Weighted Average Exercised For Cash Weighted Average Exercise Price, Exercised for cash Class of warrant or rights outstanding expired or Cancelled weighted average exercise price. Class Of Warrant Or Rights Outstanding Expired Or Cancelled Weighted Average Exercise Price Weighted Average Exercise Price, Expired or cancelled Class of warrant or right outstanding issued weighted average remaining life. Class Of Warrant Or Rights Outstanding Weighted Average Remaining Contractual Life Weighted Average Remaining Contractual Life (in years) This table lists the stock-based compensation. Stock-Based Compensation [Table] Line items represent stock-based compensation. Stock-Based Compensation [Line Items] STOCK-BASED COMPENSATION Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number Number of Shares Outstanding, Ending Balance Number of Shares Outstanding, Beginning Balance Options, grants in period, gross Granted (Shares) Number of Shares, Granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period Number of Shares, Cancelled / Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number Number of Shares, Options vested and exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price Weighted Average Exercise Price per Share Outstanding, Ending Balance Weighted Average Exercise Price per Share Outstanding, Beginning Balance Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Granted Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price Weighted Average Exercise Price per Share, Cancelled / Expired Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price Weighted Average Exercise Price, Options vested and exercisable Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Outstanding Weighted average remaining contractual term for vested portions of options granted in period. Share-based Compensation Arrangement by Share-based Payment Award, Options, Granted in Period, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Options granted Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Exercisable, Weighted Average Remaining Contractual Term Weighted Average Remaining Contractual Life, Options vested and exercisable Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Exercise Price Exercise price Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term Expected term (years) Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate Expected stock price volatility Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate Risk-free rate of interest Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate Expected dividend rate Income Statement Location [Axis] Income Statement Location [Domain] Research and development Research and development General and administrative General and administrative Allocated Share-based Compensation Expense Total stock compensation expenses Award Type [Axis] Equity Award [Domain] Represents member information pertaining to Equity Incentive Awards 2021. 2021 Equity Incentive Awards 2021 Equity Incentive Awards Represents member information pertaining to 2022 equity Incentive Plan. 2022 Equity Incentive Awards 2022 Equity Incentive Awards Title of Individual [Axis] Relationship to Entity [Domain] Executive officer Executive officer Represents the information pertaining to non-executive employees. Non-executive employees Non-executive employees Option Indexed to Issuer's Equity, Type [Axis] Option Indexed to Issuer's Equity, Type [Domain] Non Employee Stock Option Non Employee Stock Option [Member] Non Employee Stock Option Grantee Status [Axis] Grantee Status [Domain] Employees Employees Non-Employee Vesting [Axis] Vesting [Domain] Share-Based Payment Arrangement, Tranche One [Member] Tranche one Share-Based Payment Arrangement, Tranche Two [Member] Tranche two Expiration period Expiration period Number of equal monthly installments for option award vesting over the vesting period. Number of Equal Monthly Installments for Vesting of Awards Number of equal monthly installments of award Share-Based Compensation Arrangement by Share-Based Payment Award, Award Vesting Period Award vesting period Share-based Compensation Arrangement by Share-based Payment Award, Number of Shares Authorized Number of options to purchase shares Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage Vesting percentage Share based compensation arrangement number of share options available for issued. Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Options Available for Issued Number of shares options available to be issued Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount Compensation cost not yet recognized Share-Based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Period for Recognition Compensation cost not yet recognized, period for recognition This table lists the grant income. Grant Income [Table] Line items represents grant income. Grant Income [Line Items] GRANT INCOME Grants Receivable FDA's orphan products grant program, grant receivable Loss Contingencies [Table] Loss Contingencies Compensation, interest and attorney fees. Compensation, Interest And Attorney fees Compensation, interest and attorney fees Accrued Liabilities Accrued liabilities Other Expenses Other expenses Amount of legal proceedings broker awarded additional interest amount. Legal Proceedings Broker Awarded Additional Interest Amount Broker was awarded with additional in interest The percentage of accrual of post judgment interest until judgment is paid. Percentage of Accrual of Post Judgment Interest Percentage of accrual of post judgment interest "Amount of legal proceedings broker awarded accrued interest amount." Broker was awarded accrued interest Broker was awarded accrued interest "Amount of additional attorney fees awarded. Additional attorney fees awarded Additional attorney fees awarded Long-Term Purchase Commitment, Amount Payment of commitment fee Represents information pertaining to Clinical Trial Agreement with Baylor College of Medicine. Baylor College of Medicine [Member] Baylor College of Medicine Represents information about the purchases from bio techne corporation. Bio-Techne Corporation [Member] Bio-Techne Corporation Related Party Transaction, Expenses from Transactions with Related Party Total Research and development Revision of Prior Period [Axis] Revision of Prior Period [Domain] Previously Reported [Member] Previously reported Deferred Income Taxes and Other Assets [Abstract] Deferred Tax Assets Deferred Tax Assets, Operating Loss Carryforwards Net Operating Loss Carryforward Deferred tax stock based compensation. Deferred tax stock based compensation Stock Compensation Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities Accrued Expenses Amount of deferred tax assets license agreement. Deferred tax assets license agreement License Agreement Deferred Tax Assets, in Process Research and Development Capitalized R&E Deferred Tax Assets, Tax Credit Carryforwards, Research Research and Development Deferred Tax Assets, Charitable Contribution Carryforwards Charitable Contributions The amount of Deferred tax assets, operating lease liability. Deferred Tax Assets, Operating Lease Liability Operating Lease Liability Deferred Tax Assets, Gross Deferred Tax Assets Deferred Tax Assets, Valuation Allowance Less: Valuation Allowance Deferred Tax Assets, Net of Valuation Allowance Total Deferred Tax Assets Deferred Tax Liabilities, Gross [Abstract] Deferred Tax Liabilities The amount of deferred tax liability, Fixed Assets Deferred Tax Liabilities, Fixed Assets Fixed Assets The amount of deferred tax liability, Right-of-Use Assets Deferred Tax Liabilities Right of Use Assets Right-of-Use Assets Deferred Tax Liabilities, Gross Total Deferred Tax Liabilities Deferred Tax Assets, Net Net Deferred Tax Assets/(Liabilities) Income Tax Authority [Axis] Income Tax Authority [Domain] Foreign Tax Authority [Member] Foreign tax authority State and Local Jurisdiction [Member] State and local jurisdiction Income Tax [Line Items] Income Tax [Line Items] INCOME TAXES Deferred Tax Assets, Operating Loss Carryforwards, Foreign Deferred Tax Assets, Operating Loss Carryforwards, State and Local Tax credit carryforward expiration year range start. Tax credit carry forward expiration year range start Tax credit carryforwards expiration period Tax credit carryforward expiration year range end. Tax credit carry forward expiration year range end Tax credit carryforwards expiration year end Operating Loss Carryforwards The percentage of limitation for operating loss carryforwards Operating Loss Carryforwards Limitation Percentage Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount U.S. federal statutory rate Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount State taxes, net of federal benefit Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount Tax rate change Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent U.S. federal statutory rate, Percent Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent State taxes, net of federal benefit, Percent Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent Tax rate change, Percent Effective Income Tax Rate Reconciliation, Amount [Abstract] Permanent Differences Permanent differences other permanent differences. Permanent differences other permanent differences Permanent differences- Other permanent differences Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount Change in valuation allowance Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount Deferred true-up Income Tax Expense (Benefit) Income tax provision/(benefit) Represents the effective tax rate reconciliation due to other permanent differences. Effective Income Tax Rate Reconciliation Other Permanent Differences Permanent differences- Other permanent differences, Percent Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent Change in valuation allowance, Percent Effective Income Tax Rate Reconciliation, Other Adjustments, Percent Deferred true-up, Percent Effective Income Tax Rate Reconciliation, Percent Income tax provision (benefit), Percent Unrecognized Tax Benefits Unrecognized Tax Benefits Unrecognized Tax Benefits, Income Tax Penalties and Interest Accrued Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued Subsequent Event [Table] Represents information pertaining to AlloVir, Inc. AlloVir, Inc [Member] AlloVir, Inc Subsequent Event [Line Items] Subsequent Events